Charles Zacharchuk
- Oncology top 2%
- HER2/EGFR in Cancer Research 23
- Colorectal Cancer Treatments and Studies 7
- Cancer Treatment and Pharmacology 6
- Immunology top 5%
- Biosimilars and Bioanalytical Methods 7
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 6
-
- Lung Cancer Treatments and Mutations 9
-
- Monoclonal and Polyclonal Antibodies Research 15
-
- Chronic Myeloid Leukemia Treatments 6
- Co-authors
- Jonathan D. AshwellSarfraz MemonM. Belén MorenoMladen MerćepChristine PowellSusan QuinnPradip K. ChakrabortiS. Stoney Simons
- Cited by
- OncologyImmunologyGenetics
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (12 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Charles Zacharchuk
54 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 106
- Oncology 1.6k
- Immunology 912
- Genetics 272
- Pulmonary and Respiratory Medicine 764
- Radiology, Nuclear Medicine and Imaging 538
Countries citing papers authored by Charles Zacharchuk
This map shows the geographic impact of Charles Zacharchuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Zacharchuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Zacharchuk more than expected).
Fields of papers citing papers by Charles Zacharchuk
This network shows the impact of papers produced by Charles Zacharchuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Zacharchuk. The network helps show where Charles Zacharchuk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles Zacharchuk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 50 | |
| 2 | 2017 | 13 | |
| 3 | 2016 | 2 | |
| 4 | 2014 | 25 | |
| 5 | 2011 | 68 | |
| 6 | 2011 | 77 | |
| 7 | Src pathway activation correlates with treatment resistance in breast cancer and identifies patient subsets predicted to benefit from Src inhibition | 2008 | 1 |
| 8 | 2006 | 109 | |
| 9 | 2006 | 49 | |
| 10 | 1998 | 27 | |
| 11 | 1997 | 194 | |
| 12 | 1997 | 34 | |
| 13 | 1996 | 16 | |
| 14 | 1996 | 51 | |
| 15 | 1995 | 158 | |
| 16 | 1992 | 12 | |
| 17 | 1991 | 20 | |
| 18 | 1990 | 282 | |
| 19 | 1986 | 11 | |
| 20 | 1983 | 77 |
About Charles Zacharchuk
Charles Zacharchuk is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 54 papers that have together received 3.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (23 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (7 papers), Biosimilars and Bioanalytical Methods (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cancer Treatment and Pharmacology (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). The work is most often cited by research in Oncology (1.6k citations), Immunology (912 citations) and Genetics (272 citations). Charles Zacharchuk has collaborated with scholars based in United States, China and France. Frequent co-authors include Jonathan D. Ashwell, Sarfraz Memon, M. Belén Moreno, Mladen Merćep, Christine Powell, Susan Quinn, Pradip K. Chakraborti, S. Stoney Simons, H S Shin and B E Drysdale. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.